Cite

    Sandborn, W. J., Feagan, B., D'Haens, G., Hanauer, S., Wolf, D., Vermeire, S., Ghosh, S., Smith, H., Cravets, M., Frohna, P. A., Aranda, R., & Olson, A. (n.d.). safety and Efficacy of Long‐Term Treatment with Ozanimod, an Oral S1P Receptor Modulator, in Moderate to Severe Ulcerative Colitis: Touchstone Extension. American journal of gastroenterology, 111, . http://access.bl.uk/ark:/81055/vdc_100123021832.0x00000c